Eureka

Eureka Globalstars Japan 2026

7 Oct 2026 – 20 Jan 2027

Register
Register
Register

Project cooperationUpdated on 17 November 2026

Joint R&D with a Japanese SME: special delivery system for targeted cancer therapy

Owner & Founder at Avigail Lab Meditech Group Ltd

Jerusalem, Israel

About

Joint R&D with a Japanese partner (Eureka Globalstars Japan 2026): we are seeking a Japanese SME to collaborate on the development and validation of our special delivery system for targeted cancer therapy - a drug-delivery technology platform. Ideal partner: expertise in drug-delivery systems, formulation engineering, advanced materials, or preclinical testing technologies. The Israeli company leads the research; IP remains with the Israeli company as required by the Israel Innovation Authority; the Japanese partner's costs are funded by NEDO (up to 2/3, up to JPY 100M per project).

Stage

  • Early

Topic

  • Biotechnology

Type

  • Research
  • Technical

Similar opportunities